SlideShare a Scribd company logo
1 of 7
Download to read offline
Abstract .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 3
Problem Statement .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 4
Solution  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 5
Iggbo Population Health Management Calculator  .  .  .  .  .  .  . 5
Iggbo PHM Calculator .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 6
Results .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 7
Iggbo Solution Scorecard .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 7
Conclusion .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 8
Optimizing Oncology
Services Through
Pre-Infusion Phlebotomy
Shaiv Kapadia, MD | Blake Wehman, MHA
O N C O L O G Y W H I T E P A P E R
©2016 | I-570ALT*Optimizing Oncology Services Through Pre-Infusion Phlebotomy 1
Abstract:
Every year 650,000 individuals battle cancer and receive
chemotherapy treatment. As a part of their clinical protocols,
these patients must receive a simple venipuncture and diagnostic
to evaluate their complete blood count and general chemistry.
These markers influence medical decision making for oncologists,
and consequently the treatment center, to administer the
chemotherapy treatment for the patient.
Chemotherapy treatments are costly to a system to administer
without certainty the patient is eligible to receive the treatment on
their specific day and time. Therefore, health systems have built
processes and workflows in and around scheduled appointments
to ensure patients have the necessary variables approved prior
to receiving their treatment. As a result, the average wait time
in America for a patient to receive their treatment, after arrival
at the treatment center, can range from forty-five minutes (as a
barometer of excellence) to two hours (common). Combined with
the duration of treatment (ranging from one hour to four hours
depending on the chemotherapy) and the drive time to and from
the treatment center, the average cancer patient has to dedicate
nearly an entire day to receiving treatment.
While hospitals and health systems around the country are
working to reduce waste in cancer treatment centers, they have
inadvertently built processes that are leading to throughput
inefficiencies and poor patient experience. Given the current
status of delivering chemotherapy in U.S. healthcare facilities,
Iggbo set out to disrupt this inefficient and ineffective model with
one of the world-class leaders in cancer-care delivery. This case
study demonstrates how Iggbo was able to reduce wait times,
increase patient satisfaction, and simultaneously reduce costs
within one of the leading cancer treatment centers in the U.S.
Background:
Iggbo is an on-demand network of highly qualified healthcare professionals ranging from
phlebotomists to college trained registered nurses. While Iggbo primarily offers on-demand
venipunctures, the network is comprised of various skillsets including but not limited to, blood
pressure collection, weight collection, and drug screening amongst others. Iggbo’s on-demand
network of healthcare professionals give market segments, ranging from health systems to
laboratories to point-of-care device companies, instant reach and access with a sustainable
variable cost model.
Optimizing Oncology Services Through Pre-Infusion Phlebotomy 2
Problem Statement:
Health systems commonly devise workflows and processes built
around 5% of their patient population (polychromic, frail elders,
complex acute disease). It is the management of these patients
that unlocks savings across the organization and often unlocks
opportunities to increase revenue and improve efficiency by
optimizing throughput.
As exhibited below in Figure 1, health systems spend a disproportionate
amount of their resources and labor focused on a small percentage of their
total population. The at-risk population, including those battling cancer, are
the individuals whose blood draws, and thus their diagnostics, are the most
important. Without their diagnostics performed in a timely and efficient manner,
70% of medical decision making cannot occur.
FIGURE 1:
Iggbo is purpose built to tackle healthcare’s biggest problems.
Oncology
Transplants
CHF
SNFs
Diabetes
Cost Breakdown
45%
• Overutilization
• Treatment variation
• Non-compliance
5%
Polychronic, frail elders,
complex acute disease
20%
Unhealthy, at risk
75%
Generally healthy
35%
• Poor coordination
• Repeated care
• Complications
20%
Routine healthcare
Patient Cohorts
The precedent is to couple visits and treatments with blood draws. The result
is an inefficient model that could be disintermediated by simply collecting the
blood draw in advance of the treatment or physician visit. Now, equipped with
the necessary diagnostic information, the system can accelerate their decision
making and unlock efficiencies at the point-of-service and downstream
across other business units within the system including but not limited to the
laboratory, pharmacy and floor nurses.
Optimizing Oncology Services Through Pre-Infusion Phlebotomy 3
Solution:
Given the current status of delivering chemotherapy in most
U.S. healthcare facilities, Iggbo set out to disrupt this inefficient
and ineffective model with one of the United States’ world-class
leaders in cancer-care delivery. The goal was to reduce wait times,
increase patient satisfaction, and simultaneously reduce costs.
Through Iggbo’s project management team, the health system’s standard
operating procedures were assessed and assimilated into the technology
through Iggbo Assist, a proprietary product that guides the phlebotomists
through collection criteria specific to the system’s internal laboratory. By
leveraging Iggbo’s platform, the health system had the ability to collect at the
patient’s home, occupation or place of choice in advance of their scheduled
chemotherapy without contracting out to an external laboratory. All specimen
collection was then delivered back to the health system and integrated with their
oncologists’ electronic medical records, providing a higher confidence in the
values resulted from the diagnostics.
Iggbo’s project management team leveraged its proprietary Population Health
Management (PHM) True Wait Time calculator (Figure 2), included below, for
the Oncology service line, to work through the health system’s current true wait
time and the true delta in efficiency pre-Iggbo and post-Iggbo. By working with
a leading cancer treatment center for this pilot, Iggbo identified a wide range of
reports the health system was using to track wait times. Together, Iggbo and the
cancer treatment center pioneered one, true-wait time calculator to help both
entities—and future customers—evaluate the end-to-end experience for patients.
FIGURE 2:
Iggbo Population Health Management Calculator:
True Wait Time
Iggbo Wait Time Calculator	 Value 	 Metric
If they don’t have their blood work performed yet, 	 15	 Min
how long do they wait to get their blood drawn?
How long does it take to get the results back from the lab?	 10	 Min
If the chemotherapy is not pre-mixed, how long does it 	 10	 Min
take for the pharmacy to receive the order from the lab?
How long, then, does it take for the pharmacy to deliver 	 30	 Min
to the treatment center?
Total Minutes	 65	 Min
Understanding the true wait
time was vital for evaluating the
downstream impacts Iggbo had on
the pioneering cancer center. Once
the center had generated their true
wait time value, they could complete
the remainder of the Iggbo PHM
Calculator (Figure 3). Each individual
question moved the center closer
to a holistic, panoramic view of the
problem at hand.
Ultimately, each individual pain
point by the center was mitigated as
a result of their implementation of
the Iggbo solution.
Optimizing Oncology Services Through Pre-Infusion Phlebotomy 4
Administrative	 Value	Metric
Operating Day	 5	Days
Operating Hours	 9	Hours
Average Daily Patient Census	 120	Number
Average Treatment Duration	 240	Minutes
Number of Treatment Chairs	 30	Number
Days of Operation per Year	 260	 	
Operations
Do you pre-mix your chemo for patients?	 N	Y/N
(Y/N)	
If no, why not?	 Do not want to 	 Written
	 waste chemo in
	 case patients do
	 not show up or
	 their blood comes
	 back adverse
If yes, what % of pre-mixed chemo is 	 2	%
discarded/wasted?	
Do you receive any blood work in advance	 N	Y/N
of chemo today?	
If yes, what is the current strategy	 Patient comes	 Written
(draw stations, partnerships with Quest, 	 back in the day
LabCorp, etc.)?	 before
When a patient arrives for their 	 65	Minutes
chemotherapy, how long do they wait	
on average to receive treatment?***
Value generated from True Wait
Time Calculator in Figure 2
What % of patients are turned away 	 7.50%	%
because their lab values came back
disallowing them to receive chemo
that day?
FIGURE 3:
Iggbo PHM Calculator:
Oncology Services
Through the due diligence
and process engineering
performed, in conjunction
with the integration of
their laboratory protocols
into Iggbo’s on-demand
technology, Iggbo
implemented an end-to-end
solution built to:
•	 optimize throughput
•	 reduce waste
•	 increase patient quality
and outcomes
Optimizing Oncology Services Through Pre-Infusion Phlebotomy 5
Results:
Iggbo’s partnership with a leading cancer treatment center
resulted in a median wait time of zero minutes, a patient
satisfaction rating of 100%, and 100% patients reported they
would refer the Iggbo model to a friend.
By leveraging Iggbo’s on-demand workforce, the health system was able to
provide a mobile, flexible catchment in one of America’s densest metropolitan
statistical areas that was both convenient for the patient and compliant with the
system’s laboratory protocols.
The Iggbo Solution Scorecard was built to illustrate the net-impact the Iggbo
model had on the system.
Net-increase of
120patients
Adoption Rate (Assumption)	 50%
Average Time Saved by pre-infusion phlebotomy draw	 30
Total Patients Per Day	 120
Average duration of chemo	 240
Patients Turned Away Per Day	 9
Wasted Minutes For Patients Turned Away	 225
Total Minutes Saved Per Day	 2025
Net Increase in chemo appointments	 8
The result of the Iggbo implementation was a projected net-increase of 120 patients per day due
to optimized throughput.
FIGURE 4:
Iggbo Solution Scorecard
Optimizing Oncology Services Through Pre-Infusion Phlebotomy 6
Conclusion:
The American health care system has set out to accomplish the
Triple Aim for nearly two decades: reduce costs, increase quality
and improve outcomes. Through Iggbo’s on-demand network of
healthcare labor, health systems can accomplish this goal, as
proven by Iggbo’s case study with a leading cancer treatment
center. In this study, patients overwhelmingly selected Iggbo’s
phlebotomy model over the alternative, receiving a blood draw
the same day as their chemotherapy. By using Iggbo, the health
system was able to unlock thirty-three incremental hours to
deliver more care to their population while outcomes improved
as patients avoided unnecessary visits to their provider and
providers received actionable insights into their patient
population in advance of chemotherapy.
For more information
about how Iggbo
can help you or
your system, please
contact Iggbo at
info@iggbo.com
Optimizing Oncology Services Through Pre-Infusion Phlebotomy 7

More Related Content

What's hot

Final project report (1)
Final project report (1)Final project report (1)
Final project report (1)Ayan Dey
 
Demonstrating Significant Benefit for an OMP
Demonstrating Significant Benefit for an OMPDemonstrating Significant Benefit for an OMP
Demonstrating Significant Benefit for an OMPMauro Placchi
 
RF 2016 07 Health Technology Assessment
RF 2016 07 Health Technology AssessmentRF 2016 07 Health Technology Assessment
RF 2016 07 Health Technology AssessmentRichard Phillips
 
Key measures in orthopedics
Key measures in orthopedicsKey measures in orthopedics
Key measures in orthopedicsIntralign
 
Goal 1 improve the accuracy of patient identification.nps
Goal 1 improve the accuracy of patient identification.npsGoal 1 improve the accuracy of patient identification.nps
Goal 1 improve the accuracy of patient identification.npsssuser47f0be
 
Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS  Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS Nuffield Trust
 
CoArtha Technolsolutions IT for Meaningful Use
CoArtha Technolsolutions IT for Meaningful UseCoArtha Technolsolutions IT for Meaningful Use
CoArtha Technolsolutions IT for Meaningful UseMapRecruit.com
 
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...PAREXEL International
 
Computerized physician order entry (CPOE)
Computerized physician order entry (CPOE)Computerized physician order entry (CPOE)
Computerized physician order entry (CPOE)Norah Alfayez
 
Data Driven Improvement
Data Driven ImprovementData Driven Improvement
Data Driven ImprovementAllina Health
 
Getting the most out of your scpp practice review l. postnikoff
Getting the most out of your scpp practice review l. postnikoffGetting the most out of your scpp practice review l. postnikoff
Getting the most out of your scpp practice review l. postnikoffPASaskatchewan
 
7777-67-7207_Oregon_ODB_Oncology_Clinics
7777-67-7207_Oregon_ODB_Oncology_Clinics7777-67-7207_Oregon_ODB_Oncology_Clinics
7777-67-7207_Oregon_ODB_Oncology_Clinicsabrahamgage
 
Setting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centresSetting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centresPriti Gupta
 
Poster Presentation FINAL Draft
Poster Presentation FINAL DraftPoster Presentation FINAL Draft
Poster Presentation FINAL DraftMegan Handley
 
Closed loop medication administration
Closed loop medication administrationClosed loop medication administration
Closed loop medication administrationACCESS Health Digital
 
FDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActFDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActPAREXEL International
 
5_White Paper Real Time Patient Feedback
5_White Paper Real Time Patient Feedback5_White Paper Real Time Patient Feedback
5_White Paper Real Time Patient FeedbackChristopher Morgan
 
BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11William Tillman
 

What's hot (20)

Final project report (1)
Final project report (1)Final project report (1)
Final project report (1)
 
Demonstrating Significant Benefit for an OMP
Demonstrating Significant Benefit for an OMPDemonstrating Significant Benefit for an OMP
Demonstrating Significant Benefit for an OMP
 
RF 2016 07 Health Technology Assessment
RF 2016 07 Health Technology AssessmentRF 2016 07 Health Technology Assessment
RF 2016 07 Health Technology Assessment
 
Key measures in orthopedics
Key measures in orthopedicsKey measures in orthopedics
Key measures in orthopedics
 
Goal 1 improve the accuracy of patient identification.nps
Goal 1 improve the accuracy of patient identification.npsGoal 1 improve the accuracy of patient identification.nps
Goal 1 improve the accuracy of patient identification.nps
 
Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS  Carol Propper: Reform and demand response in the NHS
Carol Propper: Reform and demand response in the NHS
 
CoArtha Technolsolutions IT for Meaningful Use
CoArtha Technolsolutions IT for Meaningful UseCoArtha Technolsolutions IT for Meaningful Use
CoArtha Technolsolutions IT for Meaningful Use
 
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
 
Computerized physician order entry (cpoe) and
Computerized physician order entry (cpoe) andComputerized physician order entry (cpoe) and
Computerized physician order entry (cpoe) and
 
Computerized physician order entry (CPOE)
Computerized physician order entry (CPOE)Computerized physician order entry (CPOE)
Computerized physician order entry (CPOE)
 
Data Driven Improvement
Data Driven ImprovementData Driven Improvement
Data Driven Improvement
 
Getting the most out of your scpp practice review l. postnikoff
Getting the most out of your scpp practice review l. postnikoffGetting the most out of your scpp practice review l. postnikoff
Getting the most out of your scpp practice review l. postnikoff
 
7777-67-7207_Oregon_ODB_Oncology_Clinics
7777-67-7207_Oregon_ODB_Oncology_Clinics7777-67-7207_Oregon_ODB_Oncology_Clinics
7777-67-7207_Oregon_ODB_Oncology_Clinics
 
Trends in Early Development
Trends in Early DevelopmentTrends in Early Development
Trends in Early Development
 
Setting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centresSetting up of new pharmacovigilance centres
Setting up of new pharmacovigilance centres
 
Poster Presentation FINAL Draft
Poster Presentation FINAL DraftPoster Presentation FINAL Draft
Poster Presentation FINAL Draft
 
Closed loop medication administration
Closed loop medication administrationClosed loop medication administration
Closed loop medication administration
 
FDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures ActFDA Initiatives Under The 21st Century Cures Act
FDA Initiatives Under The 21st Century Cures Act
 
5_White Paper Real Time Patient Feedback
5_White Paper Real Time Patient Feedback5_White Paper Real Time Patient Feedback
5_White Paper Real Time Patient Feedback
 
BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11
 

Similar to Iggbo_Oncology_whitepaper_v2

This is a study case in all the photosthe SIPOC diagram bel.pdf
 This is a study case in all the photosthe SIPOC diagram bel.pdf This is a study case in all the photosthe SIPOC diagram bel.pdf
This is a study case in all the photosthe SIPOC diagram bel.pdfjkcs20004
 
I reland feb 2014
I reland feb  2014 I reland feb  2014
I reland feb 2014 Paul Grundy
 
Aust pharm march 2014
Aust pharm march  2014 Aust pharm march  2014
Aust pharm march 2014 Paul Grundy
 
A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...
A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...
A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...Joe Andelija
 
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPoint of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPAFP
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Pubrica
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialsUlrich Neumann, FRSA
 
CSR Automation: Streamlining Clinical Study Reporting
CSR Automation: Streamlining Clinical Study ReportingCSR Automation: Streamlining Clinical Study Reporting
CSR Automation: Streamlining Clinical Study ReportingClinosolIndia
 
Reducing hospital readmission rate; a strategy paper
Reducing hospital readmission rate; a strategy paperReducing hospital readmission rate; a strategy paper
Reducing hospital readmission rate; a strategy paperAhmed Otokiti MD, MBA, MPH
 
Clinical Transformation, Part II
Clinical Transformation, Part IIClinical Transformation, Part II
Clinical Transformation, Part IIMedsphere
 
STARSurgUK Protocol v5.3
STARSurgUK Protocol v5.3STARSurgUK Protocol v5.3
STARSurgUK Protocol v5.3STARSurg
 
Improving capacity and quality can help future ready your program
Improving capacity and quality can help future ready your programImproving capacity and quality can help future ready your program
Improving capacity and quality can help future ready your programGenpact Ltd
 
Structure and development of a clinical decision support system: application ...
Structure and development of a clinical decision support system: application ...Structure and development of a clinical decision support system: application ...
Structure and development of a clinical decision support system: application ...komalicarol
 
Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)Dr.SONAL GAUR
 
Quality Improvement in HIV Clinics
Quality Improvement in HIV ClinicsQuality Improvement in HIV Clinics
Quality Improvement in HIV Clinicssuchiey
 
Patients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical TrialsPatients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical TrialsCognizant
 
2_White Paper Electronic Meal Ordering
2_White Paper Electronic Meal Ordering2_White Paper Electronic Meal Ordering
2_White Paper Electronic Meal OrderingChristopher Morgan
 
Critical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docxCritical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docxmydrynan
 
VOC Health
VOC HealthVOC Health
VOC HealthEmojot
 

Similar to Iggbo_Oncology_whitepaper_v2 (20)

This is a study case in all the photosthe SIPOC diagram bel.pdf
 This is a study case in all the photosthe SIPOC diagram bel.pdf This is a study case in all the photosthe SIPOC diagram bel.pdf
This is a study case in all the photosthe SIPOC diagram bel.pdf
 
I reland feb 2014
I reland feb  2014 I reland feb  2014
I reland feb 2014
 
Aust pharm march 2014
Aust pharm march  2014 Aust pharm march  2014
Aust pharm march 2014
 
A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...
A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...
A LEAN SIX SIGMA APPROACH TO REDUCE WAITING AND REPORTING TIME IN THE RADIOLO...
 
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPoint of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...
 
white-paper-innovation-clinical-trials
white-paper-innovation-clinical-trialswhite-paper-innovation-clinical-trials
white-paper-innovation-clinical-trials
 
4_White Paper IPFM
4_White Paper IPFM4_White Paper IPFM
4_White Paper IPFM
 
CSR Automation: Streamlining Clinical Study Reporting
CSR Automation: Streamlining Clinical Study ReportingCSR Automation: Streamlining Clinical Study Reporting
CSR Automation: Streamlining Clinical Study Reporting
 
Reducing hospital readmission rate; a strategy paper
Reducing hospital readmission rate; a strategy paperReducing hospital readmission rate; a strategy paper
Reducing hospital readmission rate; a strategy paper
 
Clinical Transformation, Part II
Clinical Transformation, Part IIClinical Transformation, Part II
Clinical Transformation, Part II
 
STARSurgUK Protocol v5.3
STARSurgUK Protocol v5.3STARSurgUK Protocol v5.3
STARSurgUK Protocol v5.3
 
Improving capacity and quality can help future ready your program
Improving capacity and quality can help future ready your programImproving capacity and quality can help future ready your program
Improving capacity and quality can help future ready your program
 
Structure and development of a clinical decision support system: application ...
Structure and development of a clinical decision support system: application ...Structure and development of a clinical decision support system: application ...
Structure and development of a clinical decision support system: application ...
 
Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)
 
Quality Improvement in HIV Clinics
Quality Improvement in HIV ClinicsQuality Improvement in HIV Clinics
Quality Improvement in HIV Clinics
 
Patients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical TrialsPatients Recruitment Forecast in Clinical Trials
Patients Recruitment Forecast in Clinical Trials
 
2_White Paper Electronic Meal Ordering
2_White Paper Electronic Meal Ordering2_White Paper Electronic Meal Ordering
2_White Paper Electronic Meal Ordering
 
Critical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docxCritical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docx
 
VOC Health
VOC HealthVOC Health
VOC Health
 

Iggbo_Oncology_whitepaper_v2

  • 1. Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Problem Statement . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Solution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Iggbo Population Health Management Calculator . . . . . . . 5 Iggbo PHM Calculator . . . . . . . . . . . . . . . . . . . . . . . . 6 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Iggbo Solution Scorecard . . . . . . . . . . . . . . . . . . . . . . 7 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Optimizing Oncology Services Through Pre-Infusion Phlebotomy Shaiv Kapadia, MD | Blake Wehman, MHA O N C O L O G Y W H I T E P A P E R ©2016 | I-570ALT*Optimizing Oncology Services Through Pre-Infusion Phlebotomy 1
  • 2. Abstract: Every year 650,000 individuals battle cancer and receive chemotherapy treatment. As a part of their clinical protocols, these patients must receive a simple venipuncture and diagnostic to evaluate their complete blood count and general chemistry. These markers influence medical decision making for oncologists, and consequently the treatment center, to administer the chemotherapy treatment for the patient. Chemotherapy treatments are costly to a system to administer without certainty the patient is eligible to receive the treatment on their specific day and time. Therefore, health systems have built processes and workflows in and around scheduled appointments to ensure patients have the necessary variables approved prior to receiving their treatment. As a result, the average wait time in America for a patient to receive their treatment, after arrival at the treatment center, can range from forty-five minutes (as a barometer of excellence) to two hours (common). Combined with the duration of treatment (ranging from one hour to four hours depending on the chemotherapy) and the drive time to and from the treatment center, the average cancer patient has to dedicate nearly an entire day to receiving treatment. While hospitals and health systems around the country are working to reduce waste in cancer treatment centers, they have inadvertently built processes that are leading to throughput inefficiencies and poor patient experience. Given the current status of delivering chemotherapy in U.S. healthcare facilities, Iggbo set out to disrupt this inefficient and ineffective model with one of the world-class leaders in cancer-care delivery. This case study demonstrates how Iggbo was able to reduce wait times, increase patient satisfaction, and simultaneously reduce costs within one of the leading cancer treatment centers in the U.S. Background: Iggbo is an on-demand network of highly qualified healthcare professionals ranging from phlebotomists to college trained registered nurses. While Iggbo primarily offers on-demand venipunctures, the network is comprised of various skillsets including but not limited to, blood pressure collection, weight collection, and drug screening amongst others. Iggbo’s on-demand network of healthcare professionals give market segments, ranging from health systems to laboratories to point-of-care device companies, instant reach and access with a sustainable variable cost model. Optimizing Oncology Services Through Pre-Infusion Phlebotomy 2
  • 3. Problem Statement: Health systems commonly devise workflows and processes built around 5% of their patient population (polychromic, frail elders, complex acute disease). It is the management of these patients that unlocks savings across the organization and often unlocks opportunities to increase revenue and improve efficiency by optimizing throughput. As exhibited below in Figure 1, health systems spend a disproportionate amount of their resources and labor focused on a small percentage of their total population. The at-risk population, including those battling cancer, are the individuals whose blood draws, and thus their diagnostics, are the most important. Without their diagnostics performed in a timely and efficient manner, 70% of medical decision making cannot occur. FIGURE 1: Iggbo is purpose built to tackle healthcare’s biggest problems. Oncology Transplants CHF SNFs Diabetes Cost Breakdown 45% • Overutilization • Treatment variation • Non-compliance 5% Polychronic, frail elders, complex acute disease 20% Unhealthy, at risk 75% Generally healthy 35% • Poor coordination • Repeated care • Complications 20% Routine healthcare Patient Cohorts The precedent is to couple visits and treatments with blood draws. The result is an inefficient model that could be disintermediated by simply collecting the blood draw in advance of the treatment or physician visit. Now, equipped with the necessary diagnostic information, the system can accelerate their decision making and unlock efficiencies at the point-of-service and downstream across other business units within the system including but not limited to the laboratory, pharmacy and floor nurses. Optimizing Oncology Services Through Pre-Infusion Phlebotomy 3
  • 4. Solution: Given the current status of delivering chemotherapy in most U.S. healthcare facilities, Iggbo set out to disrupt this inefficient and ineffective model with one of the United States’ world-class leaders in cancer-care delivery. The goal was to reduce wait times, increase patient satisfaction, and simultaneously reduce costs. Through Iggbo’s project management team, the health system’s standard operating procedures were assessed and assimilated into the technology through Iggbo Assist, a proprietary product that guides the phlebotomists through collection criteria specific to the system’s internal laboratory. By leveraging Iggbo’s platform, the health system had the ability to collect at the patient’s home, occupation or place of choice in advance of their scheduled chemotherapy without contracting out to an external laboratory. All specimen collection was then delivered back to the health system and integrated with their oncologists’ electronic medical records, providing a higher confidence in the values resulted from the diagnostics. Iggbo’s project management team leveraged its proprietary Population Health Management (PHM) True Wait Time calculator (Figure 2), included below, for the Oncology service line, to work through the health system’s current true wait time and the true delta in efficiency pre-Iggbo and post-Iggbo. By working with a leading cancer treatment center for this pilot, Iggbo identified a wide range of reports the health system was using to track wait times. Together, Iggbo and the cancer treatment center pioneered one, true-wait time calculator to help both entities—and future customers—evaluate the end-to-end experience for patients. FIGURE 2: Iggbo Population Health Management Calculator: True Wait Time Iggbo Wait Time Calculator Value Metric If they don’t have their blood work performed yet, 15 Min how long do they wait to get their blood drawn? How long does it take to get the results back from the lab? 10 Min If the chemotherapy is not pre-mixed, how long does it 10 Min take for the pharmacy to receive the order from the lab? How long, then, does it take for the pharmacy to deliver 30 Min to the treatment center? Total Minutes 65 Min Understanding the true wait time was vital for evaluating the downstream impacts Iggbo had on the pioneering cancer center. Once the center had generated their true wait time value, they could complete the remainder of the Iggbo PHM Calculator (Figure 3). Each individual question moved the center closer to a holistic, panoramic view of the problem at hand. Ultimately, each individual pain point by the center was mitigated as a result of their implementation of the Iggbo solution. Optimizing Oncology Services Through Pre-Infusion Phlebotomy 4
  • 5. Administrative Value Metric Operating Day 5 Days Operating Hours 9 Hours Average Daily Patient Census 120 Number Average Treatment Duration 240 Minutes Number of Treatment Chairs 30 Number Days of Operation per Year 260 Operations Do you pre-mix your chemo for patients? N Y/N (Y/N) If no, why not? Do not want to Written waste chemo in case patients do not show up or their blood comes back adverse If yes, what % of pre-mixed chemo is 2 % discarded/wasted? Do you receive any blood work in advance N Y/N of chemo today? If yes, what is the current strategy Patient comes Written (draw stations, partnerships with Quest, back in the day LabCorp, etc.)? before When a patient arrives for their 65 Minutes chemotherapy, how long do they wait on average to receive treatment?*** Value generated from True Wait Time Calculator in Figure 2 What % of patients are turned away 7.50% % because their lab values came back disallowing them to receive chemo that day? FIGURE 3: Iggbo PHM Calculator: Oncology Services Through the due diligence and process engineering performed, in conjunction with the integration of their laboratory protocols into Iggbo’s on-demand technology, Iggbo implemented an end-to-end solution built to: • optimize throughput • reduce waste • increase patient quality and outcomes Optimizing Oncology Services Through Pre-Infusion Phlebotomy 5
  • 6. Results: Iggbo’s partnership with a leading cancer treatment center resulted in a median wait time of zero minutes, a patient satisfaction rating of 100%, and 100% patients reported they would refer the Iggbo model to a friend. By leveraging Iggbo’s on-demand workforce, the health system was able to provide a mobile, flexible catchment in one of America’s densest metropolitan statistical areas that was both convenient for the patient and compliant with the system’s laboratory protocols. The Iggbo Solution Scorecard was built to illustrate the net-impact the Iggbo model had on the system. Net-increase of 120patients Adoption Rate (Assumption) 50% Average Time Saved by pre-infusion phlebotomy draw 30 Total Patients Per Day 120 Average duration of chemo 240 Patients Turned Away Per Day 9 Wasted Minutes For Patients Turned Away 225 Total Minutes Saved Per Day 2025 Net Increase in chemo appointments 8 The result of the Iggbo implementation was a projected net-increase of 120 patients per day due to optimized throughput. FIGURE 4: Iggbo Solution Scorecard Optimizing Oncology Services Through Pre-Infusion Phlebotomy 6
  • 7. Conclusion: The American health care system has set out to accomplish the Triple Aim for nearly two decades: reduce costs, increase quality and improve outcomes. Through Iggbo’s on-demand network of healthcare labor, health systems can accomplish this goal, as proven by Iggbo’s case study with a leading cancer treatment center. In this study, patients overwhelmingly selected Iggbo’s phlebotomy model over the alternative, receiving a blood draw the same day as their chemotherapy. By using Iggbo, the health system was able to unlock thirty-three incremental hours to deliver more care to their population while outcomes improved as patients avoided unnecessary visits to their provider and providers received actionable insights into their patient population in advance of chemotherapy. For more information about how Iggbo can help you or your system, please contact Iggbo at info@iggbo.com Optimizing Oncology Services Through Pre-Infusion Phlebotomy 7